Sirtuins (SIRTs) As a Novel Target in Gastric Cancer

18Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

Abstract

Gastric cancer is a major health burden worldwide. Among all neoplasms, gastric cancer is the fifth most common and the third most deadly type of cancer. It is known that sirtuins (SIRTs), are NAD+-dependent histone deacetylases regulating important metabolic pathways. High expression of SIRTs in the human body can regulate metabolic processes; they prevent inflammation but also resist cell death and aging processes. The seven members of this family enzymes can also play a fundamental role in process of carcinogenesis by influencing cell viability, apoptosis and metastasis. This review collects and discusses the role of all seven sirtuins (SIRT1–SIRT7) in the pathogenesis of gastric cancer (GC).

Cite

CITATION STYLE

APA

Poniewierska-Baran, A., Warias, P., & Zgutka, K. (2022, December 1). Sirtuins (SIRTs) As a Novel Target in Gastric Cancer. International Journal of Molecular Sciences. MDPI. https://doi.org/10.3390/ijms232315119

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free